MEDICINOVA INC - COM NEW (MNOV)

Historical Holders from Q1 2014 to Q3 2025

Symbol
MNOV on Nasdaq
Type / Class
Equity / COM NEW
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
5,128,066
Holdings value
$6,488,274
% of all portfolios
0%
Number of holders
25
Number of buys
10
Number of sells
-6
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of MEDICINOVA INC - COM NEW (MNOV)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 5,128,066 $6,488,274 -$53,429 $1.27 25
2025 Q2 5,170,823 $6,774,834 -$46,809 $1.31 23
2025 Q1 5,202,397 $7,595,262 -$90,880 $1.46 27
2024 Q4 5,231,027 $10,985,693 +$513,458 $2.1 29
2024 Q3 4,929,543 $10,359,167 +$566,392 $2.1 30
2024 Q2 4,654,818 $6,706,694 -$28,677 $1.44 30
2024 Q1 4,674,226 $6,779,462 -$233,962 $1.45 32
2023 Q4 4,834,478 $7,252,924 -$349,778 $1.5 33
2023 Q3 5,006,666 $10,465,142 -$860,474 $2.09 30
2023 Q2 5,381,224 $12,394,508 -$434,062 $2.3 33
2023 Q1 5,588,064 $12,068,850 -$1,337,380 $2.16 40
2022 Q4 6,208,931 $12,727,368 -$1,307,417 $2.05 40
2022 Q3 6,844,003 $14,850,894 -$257,655 $2.17 32
2022 Q2 6,960,285 $17,609,042 -$424,414 $2.53 33
2022 Q1 7,128,380 $19,033,559 -$1,334,125 $2.67 29
2021 Q4 7,622,755 $20,425,618 -$239,811 $2.68 40
2021 Q3 7,648,159 $28,991,165 -$3,061,081 $3.79 38
2021 Q2 8,411,276 $35,749,549 -$15,268,151 $4.25 52
2021 Q1 11,786,829 $59,521,826 +$2,083,384 $5.05 57
2020 Q4 11,344,150 $59,675,777 +$6,680,486 $5.26 54
2020 Q3 10,076,079 $52,789,386 +$2,838,430 $5.24 51
2020 Q2 9,522,886 $51,614,201 -$1,218 $5.42 48
2020 Q1 9,605,229 $35,730,862 -$555,190 $3.72 47
2019 Q4 9,592,114 $64,645,128 -$1,263,442 $6.74 50
2019 Q3 9,758,950 $77,925,791 +$319,939 $7.96 48
2019 Q2 9,674,977 $93,150,836 +$7,378,434 $9.63 49
2019 Q1 9,064,685 $75,049,894 -$904,373 $8.28 47
2018 Q4 7,995,253 $65,323,817 +$2,853,095 $8.17 46
2018 Q3 8,766,004 $109,459,259 -$1,523,332 $12.49 45
2018 Q2 8,958,185 $71,297,050 -$5,671,416 $7.96 55
2018 Q1 9,433,289 $96,458,945 +$17,858,528 $10.22 52
2017 Q4 7,688,631 $49,745,419 -$1,697,681 $6.47 46
2017 Q3 7,918,390 $50,434,180 +$453,973 $6.37 47
2017 Q2 7,858,365 $41,335,500 +$1,083,964 $5.26 45
2017 Q1 7,650,083 $45,821,629 +$9,533,320 $5.99 44
2016 Q4 8,029,085 $48,422,492 +$3,340,642 $6.03 53
2016 Q3 7,457,572 $55,855,834 +$45,230 $7.49 50
2016 Q2 7,450,260 $56,242,931 +$486,120 $7.55 47
2016 Q1 7,403,304 $54,349,000 +$8,172,768 $7.34 39
2015 Q4 6,540,869 $23,219,950 -$1,020,021 $3.55 20
2015 Q3 6,908,603 $19,561,102 +$12,461,513 $2.81 19
2015 Q2 2,516,325 $9,941,000 +$42,625 $3.95 16
2015 Q1 2,511,772 $8,802,950 -$9,617 $3.5 18
2014 Q4 2,519,001 $7,673,000 +$461,967 $3.04 19
2014 Q3 2,376,160 $7,099,000 +$625,404 $2.99 18
2014 Q2 2,176,216 $4,416,000 -$29,227 $2.03 15
2014 Q1 2,190,080 $4,502,000 +$331,701 $2.05 16